MDSC can abrogate the expression of L-selectin (CD62L) on both CD4+ and CD8+ T cells, subverting the homing of these cells to the tumor site leading towards a dominant immunosuppressive microenvironment [17]. This evidence concerns the gene SELL and neoplasm.